LT2364302T
(en )
2017-01-25
Triazine analogs and their use as therapeutic agents and diagnostic probes
ZA201206580B
(en )
2013-05-29
Spirocyclic compounds and thier use as therapeutic agents and diagnostic probes
IL249941A0
(en )
2017-03-30
Spiro-oxindole compounds and their use as therapeutic agents
IL250435A0
(en )
2017-03-30
Use of human hil-2-mutein for the preparation of an agent for the formation of regulatory t-cells
GB0803018D0
(en )
2008-03-26
Therapeutic compounds and their use
EP2224847A4
(en )
2013-01-23
Measurement of patient physiological parameters
GB0804685D0
(en )
2008-04-16
Therapeutic compounds and their use
GB0817208D0
(en )
2008-10-29
Therapeutic apsap compounds and their use
GB0807609D0
(en )
2008-06-04
Therapeutic compounds and their use
EP2268281A4
(en )
2012-05-02
Thienopyrroles and pyrrolothiazoles as new therapeutic agents
ZA201201287B
(en )
2013-05-29
Therapeutic aryl-amido-aryl compounds and their use
GB0801080D0
(en )
2008-02-27
Therapeutic agents
GB0918392D0
(en )
2009-12-02
Diagnostic and therapeutic methods
GB0920258D0
(en )
2010-01-06
New medical agents and use thereof
SI2424870T1
(en )
2016-03-31
Therapeutic agents 713
GB0812913D0
(en )
2008-08-20
Therapeutic compounds and their use
ZA201008661B
(en )
2014-05-28
Skin cleansing formulations with silica partica particle sensory indicator
GB0922438D0
(en )
2010-02-03
Agents having tissue generative activity
SMT201700006T1
(en )
2017-03-08
Triazine analogs and their use as therapeutic agents and diagnostic probes
PT2364302T
(en )
2016-12-23
Triazine analogs and their use as therapeutic agents and diagnostic probes
GB0802128D0
(en )
2008-03-12
Therapeutic compounds and their use
EP2454276A4
(en )
2013-07-10
Therapeutic agents
GB0821539D0
(en )
2008-12-31
Therapeutic compounds and their use
GB0815134D0
(en )
2008-09-24
Therapeutic compounds and their use
GB0815389D0
(en )
2008-10-01
Needle for medical use